Melanoma, Skin cancer
Results
Phase 2
This trial compared pembrolizumab with pembrolizumab and radiotherapy for melanoma skin cancer.
It was for people with melanoma skin cancer that could not be removed with surgery or had spread to other parts of the body.
Cancer Research UK supports this trial.
Recruitment start: 16 July 2016
Recruitment end: 16 April 2018
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr James Larkin
Cancer Research UK
Experimental Cancer Medicine Centre (ECMC)
Merck, Sharp & Dohme
NIHR Clinical Research Network: Cancer
Royal Marsden NHS Foundation Trust
This is Cancer Research UK trial number CRUK/14/036.
Last reviewed: 23 May 2024
CRUK internal database number: 12764
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
Search our clinical trials database for all cancer trials and studies recruiting in the UK.
Connect with other people affected by cancer and share your experiences.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
